Trademark Overview
On Friday, April 3, 2026, a trademark application was filed for NEUPLIXO with the United States Patent and Trademark Office. The USPTO has given the NEUPLIXO trademark a serial number of 99742999. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, April 3, 2026. This trademark is owned by Definium Therapeutics US, Inc.. The NEUPLIXO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD)